SPONSOR
Regend Therapeutics
Total Trials
3
Recruiting
3
Phases
EARLY_Phase 1, Phase 1
Conditions studied: Pediatric Bronchiolitis ObliteransChronic Obstructive Pulmonary Disease (COPD)Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Regend Therapeutics is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Pediatric Bronchiolitis Obliterans, Chronic Obstructive Pulmonary Disease (COPD), Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD).
The trial portfolio spans EARLY_Phase 1, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Regend Therapeutics
How many clinical trials has Regend Therapeutics sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Regend Therapeutics, of which 3 are actively recruiting participants. These trials cover conditions including Pediatric Bronchiolitis Obliterans, Chronic Obstructive Pulmonary Disease (COPD), Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Regend Therapeutics research focus on?
Regend Therapeutics clinical trials span Pediatric Bronchiolitis Obliterans, Chronic Obstructive Pulmonary Disease (COPD), Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD). The research pipeline includes EARLY_Phase 1, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Regend Therapeutics clinical trial?
To participate in a Regend Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Regend Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Regend Therapeutics
NCT07239895 EARLY_Phase 1
Recruiting
Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells
Pediatric Bronchiolitis Obliterans
NCT07355868 EARLY_Phase 1
Recruiting
Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
Chronic Obstructive Pulmonary Disease (COPD)
NCT07275788 Phase 1
Recruiting
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology